0001209191-23-039691.txt : 20230626 0001209191-23-039691.hdr.sgml : 20230626 20230626161238 ACCESSION NUMBER: 0001209191-23-039691 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norden Gregory CENTRAL INDEX KEY: 0001405104 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 231042493 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE DRIVE STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-23 0 0001802768 Royalty Pharma plc RPRX 0001405104 Norden Gregory C/O ROYALTY PHARMA PLC 110 E. 59TH STREET NEW YORK NY 10022 1 0 0 0 0 Class A Ordinary Shares 2023-06-23 4 A 0 7747 0.00 A 64445 D Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. /s/ Sean Weisberg, as Attorney-in-Fact for Gregory Norden 2023-06-26